Home
/
IMMUNITYBIO, INC. (IBRX)
IMMUNITYBIO, INC. (IBRX) Technical Analysis
Updated: 2026-03-17 00:40 UTC · Last close: 8.21 (-2.15%)
IMMUNITYBIO, INC. (IBRX) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
IMMUNITYBIO, INC. (IBRX) closed at 8.21 (-2.15%). The chart remains in a constructive trend regime, with price holding above both the 50-day and 200-day moving averages. 20-day momentum is notably strong at +38.10%; price remains inside its roughly 52-week range (1.89–11.55); and ATR14 volatility is elevated at roughly 11.80% of price. RSI(14) stands around 51.5, which keeps the momentum picture broadly balanced. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram remains negative, suggesting momentum is still on the softer side. Recent trading volume is running below its typical 20-day average, which suggests participation remains relatively muted. The chart is currently flagging Double bottom. On the downside, 6.91 is the first support area. Holding above it helps keep the current structure more stable. Latest fundamentals snapshot: Revenue: 113.29M · Net income: -351.40M · EPS (basic): -0.38. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
Fundamentals Snapshot
Source: sec
Company
IMMUNITYBIO, INC.
Note: This is an algorithmic technical snapshot (not financial advice).